Skip Navigation LinksHome > May 2014 - Volume 21 - Issue 3 > Oncofetal Protein IMP3, a New Cancer Biomarker
Advances in Anatomic Pathology:
doi: 10.1097/PAP.0000000000000021
New Antibody/Techniques

Oncofetal Protein IMP3, a New Cancer Biomarker

Gong, Yuna MD; Woda, Bruce A. MD; Jiang, Zhong MD

Collapse Box


IMP3 is a member of a family of RNA-binding proteins that consists of IMP1, IMP2 and IMP3. These proteins contain 2 RNA recognition motifs and 4 K-homology domains that allow them to bind RNAs strongly and specifically. IMP3 is an oncofetal protein involved in embryogenesis and its expression is associated with a number of malignant neoplasms. IMP3 is associated with aggressive and advanced cancers and is specifically expressed in malignant tumors but is not found in adjacent benign tissues. Moreover, in vitro studies have shown that IMP3 promotes tumor cell proliferation, adhesion, and invasion. This review focuses on the studies of IMP3 expression in different cancers and emphasizes the potential utility of IMP3 in routine surgical pathology practice. We also discuss IMP3 as a prognostic biomarker for cancer patients’ outcomes.

© 2014 by Lippincott Williams & Wilkins.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.